Low Strength IDP-107

DRUG2 trials

Sponsors

Dow Pharmaceutical Sciences

Conditions

Acne Vulgaris

Phase 2

A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

CompletedNCT00666900

Dow Pharmaceutical SciencesAcne Vulgaris

Start: 2008-01-31End: 2009-09-30Updated: 2012-02-20

A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

CompletedNCT01194375

Dow Pharmaceutical SciencesAcne Vulgaris

Start: 2010-09-30End: 2011-12-31Updated: 2012-07-02